Anya Schiess
Managing Partner, Life Sciences Private Capital (VC)
San Francisco, California
Overview
Work Experience
Co-Managing Partner, Healthcare Private Capital (venture capital)
2022 - Current
J.P. Morgan is launching a new healthcare venture capital effort. We will invest in healthcare companies across multiple strategies aligned to specific market opportunities. Our early-stage fund will focus on novel therapeutics and technologies in several target areas including Genetic Medicine, Oncology, Neurodegenerative Disease, Rare Diseases, Autoimmunity, AI/ML platforms, Metabolic Diseases and Neuropsychology. Our venture growth stage opportunities across the healthcare spectrum, focused on treatments and technologies that save and improve patients' lives.
J.P. Morgan Ventures Energy Corporation provides commodity risk management solutions in both the physical .
Member
2020
Broadway Angels is an angel investment group made up of investors and business executives who all happen to be women.
Founder, General Partner
2015 - 2022
Co-founded Firm in 2015. Early stage healthcare fund focusing on technology infrastructure companies in healthcare and life sciences. Lead investor and board director in over 20 companies.
Purpose-built, early-stage venture investor focused on health tech
Venture Capital
2008 - 2014
Thomas, McNerney is a life-science focused fund with $600M under management, across two funds. At Thomas, McNerney, I participated in the deals in the biopharmaceutical, medical device, and diagnostics industries, including leading the seed-stage investment and follow-ons in InVitae (fka Locus Development). I held board or observer seats in: Virdante Pharmaceuticals, InVitae (NASDAQ: NVTA), Celator Pharmaceuticals (NASDAQ: CPXX) , InnoPharma (acquired by Pfizer).
Sales and Marketing Managment positions
2004 - 2008
Medtronic is the leading global medical device company. I held several management positions in the marketing and then sales organization. In Europe, I helped build the obesity business then managed the cardiac stent team, including launching 3 stents (2 follow-on drug eluting stents and one new bare metal stent). In the US, I led the service team (clinical specialists) within the sales organization, based in Chicago, IL.
Medtronic is a healthcare technology company that designs and develops AI-based products and solutions for the medical industry.
Raised $9,105,978,217.00 from NHS England.
HIV/AIDS Initiative
2003 - 2004
Consultant
2001 - 2003
McKinsey Growth Tech serves leading growth stage tech players, venture capital, and growth private equity
Equity Research
1998 - 2000
Covered biotechnology companies with Senior Analyst/Managing Director Mark Augustine.
Piper Jaffray Merchant Banking (PJMB) is a part of the asset management business of Piper Jaffray Companies
Multiple
1995 - 1998